We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA FORM 483 ANALYSIS REVEALS COMMON INSPECTION OBSERVATIONS
FDA FORM 483 ANALYSIS REVEALS COMMON INSPECTION OBSERVATIONS
June 7, 2004
Failure to adhere to regulations covering production and process control procedures is the most common observation documented by FDA investigators during pharmaceutical facility inspections, according to an agency analysis of recent Form 483 reports.